Alexion Pharmaceuticals Pays SEC $21.4 Million to Resolve FCPA Offenses
Connecticut-based Alexion Pharmaceuticals, Inc.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.